Blauvelt A, Papp K, Trivedi M, Barragan C, et al. Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks. Br J Dermatol 2024 Oct 23:ljae402. doi: 10.1093.
PMID: 39442018